Table 3: Evolution of the LDL-C goals* in cardiovascular prevention. |
||||||
Risk level |
ATP I 1988 |
ATP II-III 1994-2001 |
ATP III 2004 |
ESC/EAS 2011-2016 |
ACC/AHA 2013-2018 |
ESC/EAS 2019 |
Very high |
< 130 |
< 100 |
< 70 |
< 70 |
< 70 |
< 55 |
High |
< 160 |
< 130 |
< 100 |
< 100 |
< 100 |
< 70 |
Moderate |
– |
< 130 |
< 130 |
< 115 |
– |
< 100 |
Low |
– |
< 160 |
– |
< 115 |
– |
< 116 |
* Values in mg/dL |
|
|
|
≥ 50% reduction from basal level |
||
ATP = adult treatment panel, NCEP = National Cholesterol Education Program, ESC = European Society of Cardiology, EAS = European Atherosclerosis Society, ACC = American College of Cardiology, AHA = American Heart Association. |